Achilles Therapeutics appoints Dr Markus Dangl as Chief Scientific Officer
12. Februar 2019 07:00 ET
|
Achilles Therapeutics
Achilles Therapeutics appoints Dr Markus Dangl as Chief Scientific Officer Stevenage, UK 12 February 2019 – Achilles Therapeutics (“Achilles”), a biopharmaceutical company developing...
Achilles Therapeutics appoints Dr Markus Dangl as Chief Scientific Officer
12. Februar 2019 03:00 ET
|
Achilles Therapeutics
Achilles Therapeutics appoints Dr Markus Dangl as Chief Scientific Officer Stevenage, UK 12 February 2019 – Achilles Therapeutics (“Achilles”), a biopharmaceutical company developing...
Achilles Therapeutics receives CTA approval for Phase I/II Study in Non-Small Cell Lung Cancer
21. Januar 2019 07:00 ET
|
Achilles Therapeutics
Achilles Therapeutics receives CTA approval for Phase I/II Study in Non-Small Cell Lung CancerGround-breaking clinical trial in patients with significant unmet medical need to start this year ...
Achilles Therapeutics receives CTA approval for Phase I/II Study in Non-Small Cell Lung Cancer
21. Januar 2019 03:00 ET
|
Achilles Therapeutics
Achilles Therapeutics receives CTA approval for Phase I/II Study in Non-Small Cell Lung CancerGround-breaking clinical trial in patients with significant unmet medical need to start this year ...
Achilles Therapeutics Appoints Dr Edwin Moses as Chairman of its Board of Directors and Dr Iraj Ali as Chief Executive Officer
10. Dezember 2018 07:00 ET
|
Achilles Therapeutics
Achilles Therapeutics Appoints Dr Edwin Moses as Chairman of its Board of Directors and Dr Iraj Ali as Chief Executive Officer Stevenage, UK 10 December 2018 – Achilles Therapeutics (“Achilles” or...
Achilles Therapeutics Appoints Dr Edwin Moses as Chairman of its Board of Directors and Dr Iraj Ali as Chief Executive Officer
10. Dezember 2018 02:00 ET
|
Achilles Therapeutics
Achilles Therapeutics Appoints Dr Edwin Moses as Chairman of its Board of Directors and Dr Iraj Ali as Chief Executive Officer Stevenage, UK 10 December 2018 – Achilles Therapeutics (“Achilles” or...